Healthcare provider profile · identity verified

Todd James Corley, CNP

Nurse Practitioner · KIMBOLTON, OH · NPI 1134470214

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	445	67
Potassium Chloride	Potassium Chloride	335	48
Atorvastatin Calcium	Atorvastatin Calcium	325	64
Eliquis	Apixaban	290	46
Levothyroxine Sodium	Levothyroxine Sodium	280	46
Gabapentin	Gabapentin	255	47
Tramadol Hcl	Tramadol Hcl	232	42
Amlodipine Besylate	Amlodipine Besylate	221	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	180	19
Sertraline Hcl	Sertraline Hcl	177	34
Metoprolol Tartrate	Metoprolol Tartrate	165	34
Mirtazapine	Mirtazapine	151	27
Trazodone Hcl	Trazodone Hcl	146	30
Tamsulosin Hcl	Tamsulosin Hcl	140	25
Losartan Potassium	Losartan Potassium	133	23
Oxycodone Hcl	Oxycodone Hcl	132	27
Pantoprazole Sodium	Pantoprazole Sodium	132	38
Prednisone	Prednisone	115	31
Lorazepam	Lorazepam	113	28
Lacosamide	Lacosamide	110	suppressed
Lisinopril	Lisinopril	102	20
Donepezil Hcl	Donepezil Hcl	100	15
Clopidogrel	Clopidogrel Bisulfate	94	19
Duloxetine Hcl	Duloxetine Hcl	90	16
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	88	35
Metoprolol Succinate	Metoprolol Succinate	85	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	18
Doxycycline Hyclate	Doxycycline Hyclate	81	52
Cefdinir	Cefdinir	78	47
Memantine Hcl	Memantine Hcl	78	suppressed
Buspirone Hcl	Buspirone Hcl	76	13
Allopurinol	Allopurinol	75	14
Metformin Hcl	Metformin Hcl	75	16
Xarelto	Rivaroxaban	69	suppressed
Carvedilol	Carvedilol	68	17
Famotidine	Famotidine	66	16
Pregabalin	Pregabalin	66	suppressed
Alprazolam	Alprazolam	61	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	61	suppressed
Warfarin Sodium	Warfarin Sodium	60	suppressed
Omeprazole	Omeprazole	59	21
Divalproex Sodium	Divalproex Sodium	54	suppressed
Torsemide	Torsemide	53	11
Spironolactone	Spironolactone	51	suppressed
Hydralazine Hcl	Hydralazine Hcl	48	16
Nystatin	Nystatin	48	17
Citalopram Hbr	Citalopram Hydrobromide	46	suppressed
Finasteride	Finasteride	45	11
Ondansetron Hcl	Ondansetron Hcl	45	29
Paroxetine Hcl	Paroxetine Hcl	44	suppressed
Cephalexin	Cephalexin	42	20
Clonidine Hcl	Clonidine Hcl	41	suppressed
Januvia	Sitagliptin Phosphate	41	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Aripiprazole	Aripiprazole	40	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	24
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Entresto	Sacubitril/Valsartan	38	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	38	suppressed
Levetiracetam	Levetiracetam	38	suppressed
Fentanyl	Fentanyl	37	suppressed
Clonazepam	Clonazepam	36	suppressed
Simvastatin	Simvastatin	35	suppressed
Glipizide	Glipizide	34	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	33	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	14
Baclofen	Baclofen	31	suppressed
Glimepiride	Glimepiride	31	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	29	11
Risperidone	Risperidone	29	suppressed
Sucralfate	Sucralfate	29	suppressed
Jardiance	Empagliflozin	28	suppressed
Linzess	Linaclotide	28	suppressed
Meloxicam	Meloxicam	28	suppressed
Atenolol	Atenolol	27	suppressed
Budesonide	Budesonide	26	suppressed
Klor-Con 10	Potassium Chloride	25	suppressed
Latanoprost	Latanoprost	25	11
Lithium Carbonate	Lithium Carbonate	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Digoxin	Digoxin	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	21	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Erythromycin	Erythromycin Base	18	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Hydrocortisone	Hydrocortisone	15	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nyamyc	Nystatin	13	11
Tramadol Hcl Er	Tramadol Hcl	13	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Albuterol Sulfate	Albuterol Sulfate	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error